MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results

Core Viewpoint - MediPharm Labs Corp. is set to release its second quarter financial results for the period ending June 30, 2025, on August 14, 2025, before market opening [1] Group 1: Financial Results Announcement - The company will host a conference call and webcast on August 14, 2025, at 10:00 a.m. Eastern time to discuss its financial results [2] - Participants are encouraged to dial in approximately 15 minutes before the start of the call [3] Group 2: Company Overview - Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates and advanced derivative products [5] - The company operates a Good Manufacturing Practices certified facility with ISO standard-built clean rooms [5] - MediPharm Labs has invested in a research-driven team and state-of-the-art technology for the delivery of precision-dosed cannabis products [5] Group 3: Regulatory and Market Expansion - In 2021, MediPharm Labs received a Pharmaceutical Drug Establishment License from Health Canada, becoming the only company in North America with a commercial-scale domestic Good Manufacturing Practices License for the extraction of multiple natural cannabinoids [6] - In 2023, the company acquired VIVO Cannabis Inc., expanding its reach to medical patients in Canada, Australia, and Germany [7]